These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 7039833)

  • 61. Differences between human and goose erythrocytes in response to phorbol esters and expression of phorbol ester receptors.
    Speizer LA; Atherton SE; Sando JJ
    Cancer Res; 1987 Sep; 47(18):4830-4. PubMed ID: 3476197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biological responsiveness to the phorbol esters and specific binding of [3H]phorbol 12,13-dibutyrate in the nematode Caenorhabditis elegans, a manipulable genetic system.
    Lew KK; Chritton S; Blumberg PM
    Teratog Carcinog Mutagen; 1982; 2(1):19-30. PubMed ID: 6122277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phorbol myristate acetate inhibits growth in S49 cells: isolation of resistant variants.
    Leach KL; Powers EA; Mayo JK; Abraham I; Burnett BA; Groppi VE
    J Cell Physiol; 1987 Sep; 132(3):463-72. PubMed ID: 3477548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of ascorbic acid as the heat-stable factor from brain which inactivates the phorbol ester receptor.
    Delclos KB; Blumberg PM
    Cancer Res; 1982 Apr; 42(4):1227-32. PubMed ID: 6949636
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phorbol esters specifically inhibit induction of immunoglobulin secretion in a murine B cell leukemia.
    Simpson LG; Isakson PC
    J Immunol; 1985 Apr; 134(4):2759-66. PubMed ID: 3871817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deacylation of 12-O-[3H]tetradecanoylphorbol-13-acetate and [3H]phorbol-12,13-didecanoate in hamster skin and hamster cells in culture.
    Barrett JC; Brown MT; Sisskin EE
    Cancer Res; 1982 Aug; 42(8):3098-101. PubMed ID: 7046916
    [No Abstract]   [Full Text] [Related]  

  • 69. Specific binding of phorbol ester tumor promoters.
    Driedger PE; Blumberg PM
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):567-71. PubMed ID: 6965793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of phorbol ester binding to protein kinase C isotypes.
    Dimitrijević SM; Ryves WJ; Parker PJ; Evans FJ
    Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of tunicamycin on receptors for tumor promoters.
    Solanki V; Logani MK; Slaga TJ
    Cancer Lett; 1982 Sep; 16(3):319-25. PubMed ID: 6295623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids.
    Horowitz AD; Greenebaum E; Weinstein IB
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2315-9. PubMed ID: 6941290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular mechanisms of tumor promotion and multistage carcinogenesis.
    Weinstein IB; Arcoleo J; Backer J; Jeffrey A; Hsiao WL; Gattoni-Celli S; Kirschmeier P; Okin E
    Princess Takamatsu Symp; 1983; 14():59-74. PubMed ID: 6097583
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Down regulation of specific binding of [20-3H]phorbol 12,13-dibutyrate and phorbol ester-induced differentiation of human promyelocytic leukemia cells.
    Solanki V; Slaga TJ; Callaham M; Huberman E
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1722-5. PubMed ID: 6940185
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Membrane interaction and modulation of gene expression by tumor promoters.
    Yamasaki H; Enomoto T; Hamel E; Kanno Y
    Princess Takamatsu Symp; 1983; 14():221-33. PubMed ID: 6240488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stoichiometric binding of diacylglycerol to the phorbol ester receptor.
    König B; DiNitto PA; Blumberg PM
    J Cell Biochem; 1985; 29(1):37-44. PubMed ID: 4055921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Competitive inhibition by diacylglycerol of specific phorbol ester binding.
    Sharkey NA; Leach KL; Blumberg PM
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):607-10. PubMed ID: 6320198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells).
    Zalewski PD; Forbes IJ; Valente L; Hurst NP
    J Immunol; 1987 May; 138(9):3005-9. PubMed ID: 3494777
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cells.
    Hamel E; Martel N; Tayot JL; Yamasaki H
    Carcinogenesis; 1984 Jan; 5(1):15-21. PubMed ID: 6317223
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Receptors and endogenous analogs for the phorbol ester tumor promoters.
    Blumberg PM; Jeng AY; König B; Sharkey NA; Leach KL; Jaken S
    Carcinog Compr Surv; 1985; 10():249-62. PubMed ID: 4064007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.